The second broad ESG category, the iShares ESG Advanced lineup, features ETFs that lean toward broad market exposures, but with a beefier set of exclusions. IShares ESG Aware Moderate Allocation ETF IShares ESG Aware Aggressive Allocation ETF IShares ESG Aware Conservative Allocation ETF These range from the 30/70 mix between equity and bonds on the most conservative version to an 80/20 split in the aggressive-tilted version. These four are ETFs-of-ETFs strategies that hold a mix of the pure-play ESG Aware-branded ETFs listed above, but with different mixes of equity and fixed income exposures based on the investor’s risk tolerance. UnitedHealth Group is the 10 th largest holding in the parent index, with a 1.04% weight, but is 13th and a weight of 0.82% in ESGU.Īlso flying under the ESG Aware banner are the ESG Aware asset allocation funds. Weightings are also a major factor in the order of the largest holdings. For example, ESGU has 330 constituents compared with the 625 in the parent MSCI USA Index. These tend to be the closest ETFs to their parent indexes in the iShares lineup, but the screening process still removes plenty of companies. IShares ESG Aware 1-5 Year USD Corporate Bond ETF These funds maintain the screen against companies generating more than $20 million or 5% of their revenues from fossil fuels, weapons and tobacco manufacturing, along with firms deemed by MSCI to be involved in severe business controversies. The ESG Aware line is geared to investors who want to strike a balance between more sustainable investments without diverging too far from the performance of the broad markets. However, both funds have the same top 10 holdings, with Johnson & Johnson being the largest removed company from XVV. XVV holds 450 companies and has 32.31% of its weight in its top 10 holdings, compared with 505 holdings and 29.48% weighting of the top 10 in the iShares Core S&P 500 ETF (IVV). This generally produces a more concentrated version of the parent index. *Tons of CO 2 emitted by constituents/$M in sales
0 kommentar(er)
